Pfizer Raises 2026 Forecasts as Eliquis and Cancer Drugs Beat Expectations
Pfizer has lifted its full-year profit and sales forecasts after quarterly revenue beat expectations, driven by strong demand for its blood thinner Eliquis and its cancer medicines.
